IFF forges partnership to drive AI-led BFY snack innovation and put consumers in control of their health and wellness

Metabolic health, often referred to as syndrome X ​– affects more than 25% of the world’s adult population and includes diseases such as obesity, prediabetes, high cholesterol, and prehypertension that contribute to the spread of diseases such as type 2 diabetes, coronary stroke, and other diseases. The total cost of metabolic health is in the trillions, including healthcare expenses and lost potential economic activity.

It really is one of the biggest health hazards in the modern world and the initial focus of the partnership between IFF and Salus Optima.

Two-pronged approach to redefining consumer health

The key to the success of the association’s personalized nutrition platform is combining data-driven, science-backed recommendations with behavior change techniques, such as digital coaching, with branded products at the core of the offering.

At the first level, the collaboration leverages Salus Optima technology with IFF’s portfolio of health-promoting ingredients from its Nourish and Health & Biosciences divisions to help product developers create differentiated experiences that address issues that influence metabolic health.

IFF’s broad portfolio of ingredients is backed by science and clinically proven, including probiotics, prebiotics, plant proteins, and fiber, among others.

Second, the association is also focused on helping consumers understand their unique metabolic response to food, supplements, activity and sleep, accessible via mobile phones and wearable devices.

Salus Optima IFF company_with credit

“Partnering with Salus Optima puts us at the forefront of the personalized nutrition space,”said Nicolas Mirzayantz, president of Nourish, IFF.

Leave a Reply

Your email address will not be published. Required fields are marked *